SEC ownership of MESOBLAST LTD

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001345099.

Comparable stake leader

Gregory George

Disclosed value leader

Gregory George

Comparable rows

50/50

Latest evidence

09 Apr 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 2 signals
Latest 13D/G holder
Gregory George
Latest parsed ownership date
09 Apr 2026
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001345099
Issuer location
Melbourne, Victoria, Australia

Ownership snapshot

Top shareholders of MESOBLAST LTD (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gregory George
Disclosed value leader
Gregory George
Comparable rows
50/50
Latest evidence
09 Apr 2026
3/4/5 13D/G 13F Lead comparable stake: 22% 13D/G row: Gregory George Showing 1-8 of 50 holder rows.

Quick read

Gregory George leads the comparable SEC ownership view at 22%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gregory George's linked filing trail.
Comparable ownership Top 5
Gregory George 22%
Gueck William J. 5%
Silviu Itescu 6.1%
Eric Allen Rose 0.06%
Jane Catherine Bell 0.05%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gregory George
3/4/5 13D/G
Director, 10%+ Owner · George, Gregory
22%
from 13D/G
$2,762,560,264
166,358,342 shares
+$8,552,214 09 Apr 2026
Gueck William J.
13D/G
5%
$1,040,093,028
64,521,900 shares
$0 12 Sep 2025
Silviu Itescu
3/4/5
CEO and Managing Director, Director
6.1%
$1,424,419,060
78,958,928 shares
18 Mar 2026
Eric Allen Rose
3/4/5
Chief Medical Officer,Director, Director
0.06%
$12,093,062
714,720 shares
18 Mar 2026
Jane Catherine Bell
3/4/5
Director
0.05%
$10,532,564
622,492 shares
18 Mar 2026
Philip R. Krause
3/4/5
Director
0.02%
$4,864,500
287,500 shares
18 Mar 2026
William Murray Burns
3/4/5
Director
0.02%
$4,081,550
226,250 shares
18 Mar 2026
Philip James Facchina
3/4/5
Director
0.01%
$2,084,882
123,220 shares
18 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to buying over the last 12 months. Net value: +$8,552,214.

Buys
$8,552,214
Insiders: 1
Sells
$0
Insiders: 0
Net
+$8,552,214
Shares: +595,000
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 595,000 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 595,000 0 $8,552,214 $0 +$8,552,214
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-9 of 9 reporting-owner rows connected to MESOBLAST LTD. Open a relationship link for the CIK-to-CIK filing trail.

Rows
9
Largest Forms 3/4/5 holder
Gregory George
Net 12M change
+$8,552,214
Latest report
09 Apr 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Gregory George Director, 10%+ Owner $2,762,560,264 +$8,552,214 +0.31% Mixed 09 Apr 2026
Silviu Itescu CEO and Managing Director, Director $1,424,419,060 Mixed 18 Mar 2026
Eric Allen Rose Chief Medical Officer,Director, Director $12,093,062 Mixed 18 Mar 2026
Jane Catherine Bell Director $10,532,564 Mixed 18 Mar 2026
Philip R. Krause Director $4,864,500 Mixed 18 Mar 2026
William Murray Burns Director $4,081,550 Mixed 18 Mar 2026
Philip James Facchina Director $2,084,882 Mixed 18 Mar 2026
Lynette Elizabeth Cobley Director $905,310 Mixed 18 Mar 2026
James Michael O'Brien Chief Financial Officer Mixed 18 Mar 2026

Recent insider transactions for MESOBLAST LTD

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Gregory George MESO Ordinary Shares Purchase 38.7% 2,324,072 8,324,072 10 Apr 2026 Held by Grant George, who has granted power of attorney to Dr. George.
Gregory George MESO Ordinary Shares Purchase 38.7% 2,324,072 8,324,072 10 Apr 2026 Held by Grant George, who has granted power of attorney to Dr. George.
Gregory George MESO Ordinary Shares Purchase 13.2% 1,586,890 13,586,890 09 Apr 2026 As above.
Gregory George MESO Ordinary Shares Purchase 4.58% $8,552,214 $14.37 595,000 13,586,890 09 Apr 2026 As above.
Gregory George MESO Ordinary Shares Purchase 7.39% 886,890 12,886,890 09 Apr 2026 As above.
Gregory George MESO Ordinary Shares Purchase 50% 4,000,000 12,000,000 04 Apr 2026 Held by James George, who has granted power of attorney to Dr. George.
Gregory George MESO Ordinary Shares Purchase 50% 4,000,000 12,000,000 04 Apr 2026 Held by James George, who has granted power of attorney to Dr. George.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .